Tango Therapeutics Inc (TNGX) Insider Trading
- $13,292,773.66
- $32,409,473.59
- Oct. 25, 2024
- Rock Ventures Iv L.P. Third
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 25, 2024 | Insider | 633,000 | $6.87 | Sell | $4,348,710.00 | |
| Oct. 21, 2024 | Insider | 625,000 | $7.05 | Sell | $4,406,250.00 | |
| Sept. 13, 2024 | Major Shareholder | 67,400 | $10.53 | Sell | $709,722.00 | |
| Sept. 5, 2024 | Major Shareholder | 75,000 | $11.56 | Sell | $867,000.00 | |
| Aug. 30, 2024 | Major Shareholder | 175,000 | $11.60 | Sell | $2,030,000.00 | |
| Aug. 27, 2024 | Major Shareholder | 25,000 | $11.55 | Sell | $288,750.00 | |
| Aug. 19, 2024 | Major Shareholder | 150,000 | $10.09 | Sell | $1,513,500.00 | |
| Aug. 16, 2024 | Major Shareholder | 135,000 | $9.79 | Sell | $1,321,650.00 | |
| Aug. 1, 2024 | Major Shareholder | 40,000 | $9.80 | Sell | $392,000.00 | |
| July 30, 2024 | Insider | 95,000 | $9.70 | Buy | $921,500.00 | |
| July 24, 2024 | Major Shareholder | 200,000 | $9.82 | Sell | $1,964,000.00 | |
| July 22, 2024 | Major Shareholder | 262,740 | $9.78 | Sell | $2,569,597.20 | |
| July 17, 2024 | Major Shareholder | 550,171 | $9.79 | Sell | $5,386,174.09 | |
| July 1, 2024 | Insider | 110,731 | $8.87 | Sell | $982,183.97 | |
| June 28, 2024 | Insider | 29,000 | $8.57 | Sell | $248,530.00 | |
| June 6, 2024 | Insider | 63,000 | $7.24 | Sell | $456,120.00 | |
| May 3, 2024 | Insider | 60,000 | $7.61 | Sell | $456,600.00 | |
| May 1, 2024 | Insider | 75,000 | $7.43 | Sell | $557,250.00 | |
| Feb. 20, 2024 | Major Shareholder | 162,500 | $12.00 | Sell | $1,950,000.00 | |
| Feb. 7, 2024 | General Counsel | 1,354 | $12.62 | Sell | $17,087.48 | |
| Feb. 6, 2024 | CFO | 1,908 | $12.56 | Sell | $23,964.48 | |
| Feb. 6, 2024 | CEO | 4,681 | $12.56 | Sell | $58,793.36 | |
| Feb. 6, 2024 | Insider | 4,288 | $12.56 | Sell | $53,857.28 | |
| Nov. 1, 2023 | Insider | 7,507 | $8.39 | Sell | $62,983.73 | |
| Oct. 16, 2023 | Insider | 500,000 | $6.84 | Buy | $3,420,000.00 | |
| Oct. 13, 2023 | Insider | 750,000 | $7.07 | Buy | $5,302,500.00 | |
| Oct. 9, 2023 | Insider | 175,000 | $9.97 | Sell | $1,744,750.00 | |
| Aug. 11, 2023 | Insider | 475,000 | $5.15 | Buy | $2,446,250.00 | |
| Oct. 13, 2022 | Major Shareholder | 70,000 | $4.65 | Buy | $325,500.00 | |
| Oct. 11, 2022 | Major Shareholder | 117,000 | $4.25 | Buy | $497,250.00 | |
| Oct. 6, 2022 | Major Shareholder | 70,394 | $4.06 | Buy | $285,799.64 | |
| Oct. 4, 2022 | Major Shareholder | 25,606 | $3.67 | Buy | $93,974.02 |
Insiders are both buying and selling Tango Therapeutics Inc stock.
The insider traders at Tango Therapeutics Inc are: Rock Ventures Iv L.P. Third, Boxer Capital, Llc, Mva Investors, Llc, Adam Crystal, Boxer Capital Management, Llc, Douglas Barry, Daniella Beckman, and Barbara Weber
The most active insider trader at Tango Therapeutics Inc is Rock Ventures Iv L.P. Third with 12 trades.
Rock Ventures Iv L.P. Third has sold the most Tango Therapeutics Inc stock with a total value of $19,702,115.29.
Boxer Capital, Llc has bought the most Tango Therapeutics Inc stock with a total value of $15,791,273.66.
The most recent insider trade for Tango Therapeutics Inc was on Oct. 25, 2024.
The single biggest insider buy for Tango Therapeutics Inc was from Boxer Capital, Llc with a total value of $5,302,500.00 on Oct. 13, 2023.
The single biggest insider sell for Tango Therapeutics Inc was from Rock Ventures Iv L.P. Third with a total value of $5,386,174.09 on July 17, 2024.